Celebrating the Remarkable Career of Dr. Christopher Moertel
admin The University of Minnesota School of Medicine has announced the retirement of Dr. Christopher Moertel,...
admin
Unlocking Hope for Children with Aggressive Brain Tumors: Meet Dr. John Prensner
The landscape of pediatric oncology is witnessing a pivotal shift as CureSearch for Children’s Cancer,...
Eli Lilly’s Foundayo Faces Post-Approval FDA Scrutiny Over Liver Safety Data from Ongoing Diabetes Trial.
Eli Lilly’s newly approved oral obesity medication, Foundayo (orforglipron), has been subjected to significant post-market...
Max’s Story – More Resilient Than Cancer
The diagnostic journey for Max, a young teenager already navigating the complexities of Type 1...
Terremoto raises $108M to pursue development of drugs targeting AKT
California-based Terremoto Biosciences has successfully closed a substantial $75 million Series A financing round, positioning...
The Silent Crisis in Pediatric Oncology Lessons from Eras Battle with Acute Lymphoblastic Leukemia and the Urgent Need for Research Funding
The transition from a routine medical concern to a life-altering diagnosis often occurs in the...
Cancer Statistics 2026 Report Reveals Historic Survival Gains Driven by Immunotherapy, Highlights Persistent Disparities
The American Cancer Society’s landmark Cancer Statistics 2026 report paints a compelling picture of both...
Beeline Medicines Debuts with $300 Million Funding and Bristol Myers Squibb Pipeline to Advance Precision Therapies for Autoimmune Diseases.
Emerging from stealth on Wednesday, April 15, 2026, Beeline Medicines announced its official launch, fortified...
From Diagnosis to the Spotlight: How Medical Innovation and Resilience Transformed the Life of 12-Year-Old Cancer Survivor Isaac
The trajectory of a young life can change in the span of a single elevator...
Ultimate Hike Scaling Rugged Terrain to Accelerate Research and Support for Pediatric Cancer Patients
The Ultimate Hike, a flagship endurance program organized by CureSearch for Children’s Cancer, continues to...
